Get started
Author

Andrea Galbiati

Observed names: A. Galbiati, GALBIATI, ANDREA, Galbiati, Andrea
ORCID: 0000-0003-0725-0726
Observed ORCID: 0000-0003-0725-0726
OpenAlex ID: A5072080476
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
2021 · P. Backhaus, F. Gierse, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 112
PDF
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
2022 · Andrea Galbiati, Aureliano Zana, et al. · Journal of Nuclear Medicine · 87
PDF
Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library
2022 · Sara Puglioli, Eleonore Schmidt, et al. · Chem · 47
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
2024 · Matilde Bocci, Aureliano Zana, et al. · Journal of Controlled Release · 34
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention
2024 · Andrea Galbiati, Matilde Bocci, et al. · Journal of Medicinal Chemistry · 31
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
2022 · Aureliano Zana, Andrea Galbiati, et al. · Clinical Cancer Research · 30
Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds
2020 · Andrea Galbiati, Aureliano Zana, et al. · European Journal of Medicinal Chemistry · 27
PDF
Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy
2022 · Francesco Bartoli, Philip Elsinga, et al. · Pharmaceuticals · 22
PDF
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells
2023 · Andrea Galbiati, Stefania Bova, et al. · European Journal of Medicinal Chemistry · 19
PDF
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics
2023 · Andrea Galbiati, Paulina Dorten, et al. · Journal of Nuclear Medicine · 18
PDF
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds
2021 · Andrea Galbiati, Aureliano Zana, et al. · ACS Medicinal Chemistry Letters · 17
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives
2023 · Andrea Galbiati, Aureliano Zana, et al. · Molecules · 16
PDF
Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro
2019 · Gregorio Cullia, Stefano Bruno, et al. · ACS Medicinal Chemistry Letters · 16
Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics
2024 · Andrea Galbiati, Matilde Bocci, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 11
PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al. · Molecular Cancer Therapeutics · 9
Mass Spectrometry-Based Method for the Determination of the Biodistribution of Tumor-Targeting Small Molecule–Metal Conjugates
2022 · Ettore Gilardoni, Aureliano Zana, et al. · Analytical Chemistry · 8
PDF
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™
2024 · Tony Georgiev, Lucrezia Principi, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 7
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker
2023 · Lydia Bisbal Lopez, Domenico Ravazza, et al. · Frontiers in Pharmacology · 7
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule–Drug Conjugates Elicits Potent In Vivo Anticancer Activity
2024 · Matilde Bocci, Lucrezia Principi, et al. · Bioconjugate Chemistry · 6
Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025 · Matilde Bocci, Lucrezia Principi, et al. · Molecular Cancer Therapeutics · 5
Synthesis and Reactivity of 3‐Halo‐4,5‐dihydroisoxazoles: An Overview
2021 · Aureliano Zana, Andrea Galbiati · ChemistrySelect · 5
A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors
2026 · Andrea Galbiati, Paola Roccabianca, et al. · Journal of Medicinal Chemistry · 3
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein
2026 · Matilde Bocci, Laura Lucaroni, et al. · Molecular Pharmaceutics · 3
Isolation of a Natural Killer Group 2D Small‐Molecule Ligand from DNA‐Encoded Chemical Libraries
2022 · Sheila Dakhel, Andrea Galbiati, et al. · ChemMedChem · 3
Expression patterns of fibroblast activation protein and extra-domain B fibronectin in canine malignant tumors
2026 · Silvia Dell’Aere, Elisa Maria Gariboldi, et al. · Frontiers in Veterinary Science · 1
PDF
Works count: 70
Citation count: 544
H-index: 13
I10-index: 14
Year
Topic
Type